DongKook Pharmaceutical (Korea) Volatility

086450 Stock  KRW 16,590  240.00  1.47%   
At this point, DongKook Pharmaceutical is very steady. DongKook Pharmaceutical secures Sharpe Ratio (or Efficiency) of 0.0183, which denotes the company had a 0.0183% return per unit of risk over the last 3 months. We have found twenty-three technical indicators for DongKook Pharmaceutical Co, which you can use to evaluate the volatility of the firm. Please confirm DongKook Pharmaceutical's Mean Deviation of 1.37, variance of 4.16, and Standard Deviation of 2.04 to check if the risk estimate we provide is consistent with the expected return of 0.0381%. Key indicators related to DongKook Pharmaceutical's volatility include:
30 Days Market Risk
Chance Of Distress
30 Days Economic Sensitivity
DongKook Pharmaceutical Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of DongKook daily returns, and it is calculated using variance and standard deviation. We also use DongKook's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of DongKook Pharmaceutical volatility.
  
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as DongKook Pharmaceutical can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of DongKook Pharmaceutical at lower prices to lower their average cost per share. Similarly, when the prices of DongKook Pharmaceutical's stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.

DongKook Pharmaceutical Market Sensitivity And Downside Risk

DongKook Pharmaceutical's beta coefficient measures the volatility of DongKook stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents DongKook stock's returns against your selected market. In other words, DongKook Pharmaceutical's beta of -0.37 provides an investor with an approximation of how much risk DongKook Pharmaceutical stock can potentially add to one of your existing portfolios. DongKook Pharmaceutical Co exhibits very low volatility with skewness of 1.65 and kurtosis of 6.59. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure DongKook Pharmaceutical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact DongKook Pharmaceutical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze DongKook Pharmaceutical Demand Trend
Check current 90 days DongKook Pharmaceutical correlation with market (Dow Jones Industrial)

DongKook Beta

    
  -0.37  
DongKook standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  2.09  
It is essential to understand the difference between upside risk (as represented by DongKook Pharmaceutical's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of DongKook Pharmaceutical's daily returns or price. Since the actual investment returns on holding a position in dongkook stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in DongKook Pharmaceutical.

DongKook Pharmaceutical Stock Volatility Analysis

Volatility refers to the frequency at which DongKook Pharmaceutical stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with DongKook Pharmaceutical's price changes. Investors will then calculate the volatility of DongKook Pharmaceutical's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of DongKook Pharmaceutical's volatility:

Historical Volatility

This type of stock volatility measures DongKook Pharmaceutical's fluctuations based on previous trends. It's commonly used to predict DongKook Pharmaceutical's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for DongKook Pharmaceutical's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on DongKook Pharmaceutical's to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. DongKook Pharmaceutical Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

DongKook Pharmaceutical Projected Return Density Against Market

Assuming the 90 days trading horizon DongKook Pharmaceutical Co has a beta of -0.3739 . This suggests as returns on the benchmark increase, returns on holding DongKook Pharmaceutical are expected to decrease at a much lower rate. During a bear market, however, DongKook Pharmaceutical Co is likely to outperform the market.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to DongKook Pharmaceutical or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that DongKook Pharmaceutical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a DongKook stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
DongKook Pharmaceutical Co has an alpha of 0.0148, implying that it can generate a 0.0148 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Predicted Return Density   
       Returns  
DongKook Pharmaceutical's volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how dongkook stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives a DongKook Pharmaceutical Price Volatility?

Several factors can influence a stock's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

DongKook Pharmaceutical Stock Risk Measures

Assuming the 90 days trading horizon the coefficient of variation of DongKook Pharmaceutical is 5474.09. The daily returns are distributed with a variance of 4.35 and standard deviation of 2.08. The mean deviation of DongKook Pharmaceutical Co is currently at 1.39. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.73
α
Alpha over Dow Jones
0.01
β
Beta against Dow Jones-0.37
σ
Overall volatility
2.08
Ir
Information ratio -0.05

DongKook Pharmaceutical Stock Return Volatility

DongKook Pharmaceutical historical daily return volatility represents how much of DongKook Pharmaceutical stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company accepts 2.085% volatility on return distribution over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7298% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

About DongKook Pharmaceutical Volatility

Volatility is a rate at which the price of DongKook Pharmaceutical or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of DongKook Pharmaceutical may increase or decrease. In other words, similar to DongKook's beta indicator, it measures the risk of DongKook Pharmaceutical and helps estimate the fluctuations that may happen in a short period of time. So if prices of DongKook Pharmaceutical fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea. DongKook Pharm is traded on Korean Securities Dealers Automated Quotations in South Korea.
DongKook Pharmaceutical's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on DongKook Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much DongKook Pharmaceutical's price varies over time.

3 ways to utilize DongKook Pharmaceutical's volatility to invest better

Higher DongKook Pharmaceutical's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of DongKook Pharmaceutical stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. DongKook Pharmaceutical stock volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of DongKook Pharmaceutical investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in DongKook Pharmaceutical's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of DongKook Pharmaceutical's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

DongKook Pharmaceutical Investment Opportunity

DongKook Pharmaceutical Co has a volatility of 2.09 and is 2.86 times more volatile than Dow Jones Industrial. 18 percent of all equities and portfolios are less risky than DongKook Pharmaceutical. You can use DongKook Pharmaceutical Co to enhance the returns of your portfolios. The stock experiences a large bullish trend. Check odds of DongKook Pharmaceutical to be traded at W18249.0 in 90 days.

Good diversification

The correlation between DongKook Pharmaceutical Co and DJI is -0.13 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding DongKook Pharmaceutical Co and DJI in the same portfolio, assuming nothing else is changed.

DongKook Pharmaceutical Additional Risk Indicators

The analysis of DongKook Pharmaceutical's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in DongKook Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some common measures of DongKook Pharmaceutical stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

DongKook Pharmaceutical Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against DongKook Pharmaceutical as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. DongKook Pharmaceutical's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, DongKook Pharmaceutical's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to DongKook Pharmaceutical Co.

Complementary Tools for DongKook Stock analysis

When running DongKook Pharmaceutical's price analysis, check to measure DongKook Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DongKook Pharmaceutical is operating at the current time. Most of DongKook Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of DongKook Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DongKook Pharmaceutical's price. Additionally, you may evaluate how the addition of DongKook Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance